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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYFragile X syndrome (FXS) is caused by the absence of the fragile Xmental retardation protein (FMRP).We have previously generated FXS-
induced pluripotent stem cells (iPSCs) from patients’ fibroblasts. In this study, we aimed at unraveling the molecular phenotype of the
disease. Our data revealed aberrant regulation of neural differentiation and axon guidance genes in FXS-derived neurons, which are regu-
lated by the RE-1 silencing transcription factor (REST). Moreover, we found REST to be elevated in FXS-derived neurons. As FMRP is
involved in the microRNA (miRNA) pathway, we employed miRNA-array analyses and uncovered several miRNAs dysregulated in
FXS-derived neurons.We found hsa-mir-382 to be downregulated in FXS-derived neurons, and introduction ofmimic-mir-382 into these
neurons was sufficient to repress REST and upregulate its axon guidance target genes. Our data link FMRP and REST through the miRNA
pathway and show a new aspect in the development of FXS.INTRODUCTION
Fragile X syndrome (FXS) affects approximately 1 in every
4,000 boys and 1 in 8,000 girls worldwide (Callan and Zar-
nescu, 2011; Penagarikano et al., 2007). It is now believed
that FXS is the leading cause of inherited intellectual
disability in males and one of the major monogenic causes
for autism (Boyle and Kaufmann, 2010; Callan and Zar-
nescu, 2011; Penagarikano et al., 2007; Wang et al.,
2012). The syndrome is caused primarily by an expansion
of a CGG repeat at the 50 untranslated region (UTR) of
the fragile X mental retardation gene 1 (FMR1). This repeat
expansion leads to CpGmethylation, which spreads to the
FMR1 promoter, modifications in chromatin conformation
of the FMR1 gene, and silencing of the gene expression.
Subsequently, the fragile X mental retardation protein
(FMRP) is no longer produced (Coffee et al., 1999, 2002;
Sutcliffe et al., 1992).
FMRP is a highly conserved protein, expressed in mam-
malsmainly in the brain and testes (Devys et al., 1993; San-
toro et al., 2012; Verkerk et al., 1991). In the brain, FMRP is
found primarily in neurons, where it plays an important
role in synaptic plasticity (Devys et al., 1993). FMRP is an
RNA-binding protein that acts as a translation regulator
by either stalling polyribosomes or inhibiting translation
initiation (Ashley et al., 1993; Feng et al., 1997; Khandjian
et al., 2004; Napoli et al., 2008; Stefani et al., 2004). It may
also regulate mRNA levels through the microRNA (miRNA)
pathway, as work on both Drosophila and mammalian cells
revealed association of FMRPwith components of the RNA-
induced silencing complex and several miRNAs (Caudy
et al., 2002; Ishizuka et al., 2002; Jin et al., 2004; PlanteStemet al., 2006). FMRPwas also shown to associatewith specific
miRNAs, which together select and repress targetmRNAs to
regulate neuronal morphology (Edbauer et al., 2010).
Several works have implicated a role for FMRP in neuro-
genesis, and although some of the results were contradict-
ing, all of these studies have shown impairment in
dendritic spine morphology, maturation or pruning, or
abnormal gene expression during neural development
that may persist to adulthood (Bhattacharyya et al., 2008;
Castre´n et al., 2005; Comery et al., 1997; Galvez et al.,
2005; Irwin et al., 2001; Tessier and Broadie, 2008). Other
studies have shown FMRP to be crucial for the regulation
of timing and proliferation capacities of neural progenitor
cells (NPCs), thus regulating the proper number of neurons
(Callan et al., 2010; Egger et al., 2008; Luo et al., 2010).
All of these data place FMRP as an important regulator
of proper development and maturation of the neural
network.
Another key factor important for proper brain develop-
ment is the repressor element 1 silencing transcription fac-
tor (REST) (Chen et al., 1998). REST is considered a master
negative regulator of neurogenesis, regulating the pool size
and timing of differentiation of different neural lineages
(Chen et al., 1998; Covey et al., 2012; Satoh et al., 2013;
Schoenherr and Anderson, 1995). REST is expressed in em-
bryonic stem cells (ESCs), NPCs, and nonneuronal cells,
where it suppresses neuron-specific genes, in contrast to
differentiated neurons where it is silenced (Chen et al.,
1998; Schoenherr and Anderson, 1995). REST both regu-
lates and is regulated by brain specific miRNAs and has
been implicated to be involved in pluripotency and neuro-
degenerative pathologies (Gonza´lez-Castan˜eda et al., 2013;Cell Reports j Vol. 4 j 37–46 j January 13, 2015 j ª2015 The Authors 37
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Figure 1. Differentially Expressed Genes
in FXS versus Control Cells
(A) PCA on total gene expression profiles of
control (WT) and FXS-derived cells shows
clustering by cell type.
(B) The same profiles were used for hierar-
chical clustering using Pearson correlation
exhibiting fibroblasts, iPSCs, and neurons
to group apart.
(C) Downregulated genes in FXS iPSCs, fi-
broblasts, or neurons, which passed a sta-
tistically significant threshold of differen-
tial expression, were analyzed for different
cellular processes or pathways using Func-
tional annotation clustering with the DAVID
functional annotation clustering tool
(http://david.abcc.ncifcrf.gov/). FXS iPSCs
showed no significant GO term enrichment
for downregulated genes. Downregulated
genes in FXS fibroblasts exhibit a significant
enrichment for metal binding proteins while
FXS-derived neurons display a significant
enrichment for axonogenesis and neuron
differentiation.
(D) DNA-microarray analysis revealed several axonal guidance genes with markedly lower expression levels in FXS-derived neurons
compared with control (WT) (columns represent average values of two control microarrays for WT and three FXS microarrays for FXS; scale
bars represent SE).
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Molecular Defects of FXS-iPSCs-Derived NeuronsGopalakrishnan, 2009; Hermanson, 2008; Marullo et al.,
2010; Ooi and Wood, 2007; Zuccato et al., 2003).
We have previously generated both ESCs and induced
pluripotent stem cells (iPSCs) derived from FXS patients
(Bar-Nur et al., 2012; Eiges et al., 2007; Urbach et al.,
2010). Although the functions of FMRP have been
studied extensively, the underlyingmolecularmechanisms
causing the severe neuronal phenotypes are still largely
unknown. In this study, we aim to understand the molecu-
lar pathology underling FXS using FXS-derived iPSCs,
NPCs, and neurons. Our study suggests a major role for
REST in the molecular pathology of FXS neurons. A better
understanding of the developmental processes dysregu-
lated in FXS will help in the search for a treatment to alle-
viate or even correct some of the abnormal molecular
phenotypes.RESULTS
Downregulation of Neuronal Differentiation and
Axon Guidance Genes in FXS-Derived Neurons
In order to understand the molecular pathology in FXS, we
differentiated FXS-derived iPSCs into either NPCs (FXS-
derived NPCs) or neurons (FXS-derived neurons) using
two different protocols (Bar-Nur et al., 2012; Kim et al.,
2010). We next compared global gene expression profiles38 Stem Cell Reports j Vol. 4 j 37–46 j January 13, 2015 j ª2015 The Authorof two normal control cell lines with five different FXS
clones generated from three different patients, in three
different categories of cell types: fibroblasts, iPSCs, and
neurons (derived from the aforementioned fibroblasts or
iPSCs, respectively) using DNA microarray data. Principal
component analysis (PCA) shows that FXS and control cells
cluster according to cell type and not by genetic origin (Fig-
ure 1A). This observation was further supported by hierar-
chical clustering showing that FXS and control cells from
each cell type category cluster together (Figure 1B). Next,
ANOVA analysis was performed for each cell type category
to detect differentially expressed genes (Figure S1A avail-
able online). Only genes that passed a threshold of p <
0.05 with fold change > 2 and are expressed in either FXS
or control cells were further analyzed. FXS fibroblasts taken
from patients exhibited a very mild difference, with 106
genes that were significantly downregulated in FXS cells
compared with control fibroblasts (Figure 1C). Functional
annotation analysis of the 106 downregulated genes using
the Database for Annotation, Visualization and Integrated
Discovery (DAVID) functional annotation clustering tool
showed enrichment formetal binding proteins (Figure 1C).
We next compared the global gene expression of iPSCs
derived from the above fibroblasts. Surprisingly, control
and FXS-derived iPSCs were almost identical in their total
gene expression profiles, as only 21 genes showed a signif-
icant difference in expression levels (Figure 1C). In thiss
A B
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Figure 2. REST Regulates Neuron Differ-
entiation and Axon Guidance Genes and
Is Aberrantly Expressed in FXS-Derived
Neurons
(A) Binding sites locations of REST on its
target genes within the downregulated
genes in FXS neurons as predicted by the
Amadeus (Allegro/Amadeus) BPM v.1.0
software (http://acgt.cs.tau.ac.il/allegro/).
(B) RESTmRNA levels were analyzed in iPSCs
and neurons by qRT-PCR. Results show that
in FXS-derived neurons from three inde-
pendent patients (FXS-A, FXS-B, FXS-C),
REST mRNA levels are upregulated in
contrast to the downregulation seen in
control (WT) neurons.
(C) REST target genes are upregulated dur-
ing neural differentiation; however, their
upregulated is limited in FX-derived neu-
rons, as seen by qRT-PCR analysis.
qRT-PCR analyses were performed on three
to four biological repeats; scale bars repre-
sent SE, *p < 0.05, **p < 0.005 using Stu-
dent’s t test.
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Molecular Defects of FXS-iPSCs-Derived Neuronscase, we found no significant gene ontology (GO) term
enrichment for any cellular process common to these
genes (Figure 1C). Finally, we repeated the gene expression
analysis with neurons derived from either the control
iPSCs or FXS-derived iPSCs. Neurons showed the largest
difference in global gene expression than all other cell
types, with 198 genes being significantly downregulated
(Figures 1C and S1A). Functional annotation analysis re-
vealed that the FXS-derived neurons were downregulated
in processes such as neuron differentiation, neuron pro-
jection development, and axonogenesis, all of which
found to be statistically significant with a Benjamini
correction for multiple tests of p < 5 3 104 (Figure 1C).
We next wanted to analyze whether the downregulated
genes in FXS-derived neurons are part of a specific cellular
pathway. For this aim, we used the Kyoto Encyclopedia
for Genes and Genomes (KEGG). The highest ranking
pathway generated by KEGG revealed a significant enrich-
ment of the downregulated genes for the axon guidance
pathway, which is a key step in neural network formation
and determines which way a newly formed growth cone
will turn. Expression levels of representative downregu-
lated axon guidance genes are shown in Figure 1D. To
verify that the downregulation observed in neural genes
in FXS-derived neurons is not a result of incomplete dif-
ferentiation, we looked at various key neural genes.
Expression levels of TUBB3, NESTIN, and HOMER3 were
examined and showed similar or even higher expression
levels in FXS-derived neurons compared with control cells
(Figure S1B).StemMost Downregulated Genes in FXS-Derived Neurons
Are Regulated by REST
During neural differentiation, specific transcription factors
act at different stages to orchestrate the process of turning
on tissue specific genes and shutting off pluripotency
genes. We searched for common promoter motifs within
the downregulated genes of FXS-derived neurons. We
used two different platforms for this analysis, the inte-
grated Allegro/Amadeus motif discovery platform and the
DAVID functional annotation clustering tool together
with the UCSC transcription factor binding site data.
Both platforms identified REST as a candidate transcription
factor, regulating over half of the downregulated genes
with a statistical significance by Benjamini correction of
p value = 1.9 3 107 in DAVID and p value = 2.8 3 1017
in Allegro/Amadeus. The Allegro/Amadeus software indi-
cated most target genes to have the REST recognition
sequence at a very close proximity to their transcription
start site (Figure 2A).
REST Fails to Undergo Downregulation as
Differentiation Progresses in FXS-Derived Neurons
REST acts to suppress neural genes in nonneuronal tissues,
and its expression levels must be downregulated as neural
differentiation progresses (Ballas et al., 2005; Paquette
et al., 2000; Schoenherr and Anderson, 1995). To investi-
gate whether aberrant gene expression in FXS-derived
neurons results from abnormal expression of REST during
neural differentiation, we performed a qRT-PCR analysis
on FXS-derived iPSCs, NPCs, and neurons. Our resultsCell Reports j Vol. 4 j 37–46 j January 13, 2015 j ª2015 The Authors 39
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Molecular Defects of FXS-iPSCs-Derived Neuronsshow that RESTmRNA levels increase during early differen-
tiation of iPSCs into NPCs, both in control and FXS cells
(Figures S2A and S2B). When differentiating the cells into
neurons, RESTmRNA levels decrease in control cells, as ex-
pected. In contrast, FXS-derived neurons fail to downregu-
late REST as differentiation progresses, resulting in a
marked difference in REST mRNA levels between control
and all FXS-derived neurons (Figure 2B). In order to verify
a progressive differentiation process, we analyzed the
FXS-derived NPCs and neurons for key neural markers by
quantitative RT-PCR (qRT-PCR). Results show that FXS-
derivedNPCs express higher levels ofNESTIN than neurons
while neurons express higher levels of TUBB3 than NPCs
(Figures S2C and S2D).
Our analysis of the downregulated genes in FXS-derived
neurons using the KEGG pathway database revealed that
some of the genes are key players in the axon guidance
pathway. Genes in this pathway such as ROBO3, DCC,
and SLIT1 were suggested to be direct targets of REST by
large-scale chromatin immunoprecipitation assay or bio-
informatically by the ENCODE project (Johnson et al.,
2007; Myers et al., 2011). We have thus verified the differ-
ences in expression levels of the axon guidance genes in
control and FXS-derived neurons using a qRT-PCR anal-
ysis. The analysis confirmed that the axon guidance genes
are indeed significantly downregulated in all FXS lines-
derived neurons compared with control neurons (Fig-
ure 2C). This sharp downregulation is not a result of
failure to turn on the neural genes as differentiation pro-
gresses, but rather a result of suppression that occurs from
high levels of the regulating repressor of these genes. This
was verified by analyzing differences in expression of
ROBO3, SLIT1, and DCC between iPSCs and neurons of
FXS and control cells. Results show that expression
of these axon guidance genes is upregulated in both con-
trol and FXS neurons compared with iPSCs. However,
in control cells, the increase in expression following
differentiation is very dramatic in contrast to FXS cells
where the increase in expression after differentiation is
subdued (Figure 2C). Furthermore, other neural markers
such as NESTIN and TUBB3 show similar expression levels
between control and FXS-derived neurons (Figures S2E
and S2F).
FXS-Derived Neurons Exhibit Downregulation of
Specific miRNAs
We next sought to decipher the association between FMRP
and REST. As FMRP is associated with the miRNA machin-
ery and REST is regulated by several brain specific miRNAs,
we compared miRNA arrays from both control and
FXS-derived neurons. When looking at brain-associated
miRNAs, we could observe variations in the levels of
some neural miRNAs. When comparing control and FXS-40 Stem Cell Reports j Vol. 4 j 37–46 j January 13, 2015 j ª2015 The Authorderived neurons, some miRNAs are present at the same
levels, while others show either much lower or higher
levels between the two cell types (Figure 3A). It was visible
from the results, however, that overall, many miRNAs are
downregulated in FXS-derived compared with control neu-
rons (Figure 3B). Surprisingly, whenwe set a cutoff of 4-fold
difference inmaturemiRNA levels, we could not detect any
upregulated miRNAs associated with the FXS-derived neu-
rons, and we were left only with miRNAs that are downre-
gulated (Figure 3B).
hsa-mir-382 Regulates RESTmRNA Levels
From the group of miRNAs downregulated in FXS-derived
neurons, we identified six miRNAs with target sites on the
REST transcript (Figure 3B). We scanned the REST tran-
script for possible recognition sites for these miRNAs us-
ing the UCSC Genome Browser on Human February
2009 (GRCh37/hg19) Assembly using the miRcode
miRNA sites track (UCSC miRcode) (Jeggari et al., 2012).
Two of the six candidate miRNAs had two binding sites
each, with at least one site at the 30 UTR. One of those
miRNAs was hsa-mir-382 that was previously associated
with brain function and found to be expressed mainly
in the brain (Mor et al., 2013). Hsa-mir-382 has two pre-
dicted binding sites on the REST transcript, one at the first
exon and one at the 30 UTR, as predicted by UCSC
miRcode, and was found with high levels in control neu-
rons and markedly low levels in FXS-derived neurons (Fig-
ures 3A–3C). To examine the association of hsa-mir-382
with REST, we transfected iPSCs with either mimic hsa-
mir-382, mimic hsa-mir-370 that is also abundant in con-
trol compared with FXS-derived neurons and has one
complementary site on the REST transcript (Figures 1B
and 1C) or mimic hsa-mir-409 that behaves as the two
former miRNAs but has no complementary sites on the
REST transcript. qRT-PCR analysis of transfected iPSCs
for REST mRNA levels shows that hsa-mir-382 was able
to significantly decrease REST transcripts levels as opposed
to the other two miRNAs, that did not exhibit any
detectable differences (Figure 3D). After successful down-
regulation of REST in iPSCs by mimic hsa-mir-382, we
aimed to see whether introduction of hsa-mir-382 could
downregulate the high levels of REST in FXS-derived neu-
rons and the effect it would have on the axon guidance
genes. For this aim, we have again differentiated FXS-
derived iPSCs into neurons. At day 25 of the differentia-
tion process, the maturing neurons were transfected
with the mimic hsa-mir-382. The transfected neurons
were then analyzed for REST expression and REST
protein content. It is apparent from the qRT-PCR results
that introduction of mimic hsa-mir-382 for 30 hr into
FXS-derived neurons caused a marked downregulation
of REST (Figure 4A). Western blot analysis from proteins
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Figure 3. FXS Neurons Display Abnormal
miRNAs Levels
(A) Analysis of expression of brain associ-
ated miRNAs in control (WT) and FXS neu-
rons (columns represent average from two
miRNA arrays of two biological repeats for
each cell type [WT and FXS]).
(B) miRNAs arrays revealed significant dif-
ferences in mature miRNAs levels between
FXS-derived and control neurons (cutoff was
set to 4-fold change). All miRNAs with
target sites on the REST transcript are
marked in red.
(C) Schematic representation of the REST
gene and the predicted binding sites of hsa-
mir-382 marked by red asterisks and hsa-
mir-370 marked with a green asterisk.
(D) hsa-mir-382, hsa-mir-370, and hsa-mir-
409 were transfected into iPSCs using mimic
miRNAs. Cells were grown for 24 hr, har-
vested and RNA was purified. Only trans-
fection of mimic-mir-382 was sufficient to
significantly lower REST mRNA to 23% of its
normal levels (three biological repeats;
scale bars represent SE, *p < 0.05 using
Student’s t test).
Stem Cell Reports
Molecular Defects of FXS-iPSCs-Derived Neuronsextracts showed a downregulation of REST also at the pro-
tein level (Figure 4B). REST protein levels of control trans-
fected neurons mimic transfected for 30 hr and mimic
transfected for 45 hr show a progressive and marked
decrease over time (Figure 4C). We next analyzed whether
the downregulation of REST by the mimic hsa-mir-382Stemwould affect its axon guidance target genes. We thus
analyzed expression of neural genes by qRT-PCR in the
30 hr mimic-transfected neurons. The results clearly indi-
cate significant upregulation of all three REST target axon
guidance genes following overexpression of hsa-mir-382
(Figure 4D).Cell Reports j Vol. 4 j 37–46 j January 13, 2015 j ª2015 The Authors 41
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Figure 4. Correction of the Aberrant Molecular Phenotype by Overexpression of hsa-mir-382
Different FXS cell lines were transfected with mimic hsa-mir-382 or control transfection, cells were than harvested for either RNA or
protein.
(A) qRT-PCR was performed to analyze REST expression and shows a marked downregulation of REST in mimic transfected cells after 30 hr.
(B) Western blot analysis of extract from the same time point shows lower levels of the REST protein.
(C) Quantification of western blots of extracts taken from control or mimic transfected cells after 30 and 45 hr show a progressive decrease
of REST.
(D) REST axon guidance target genes show a significant upregulation after mimic treatment as observed by qRT-PCR.
All graphs represent three biological repeats; scale bars represent SE, *p < 0.05, **p < 0.005 using Student’s t test.
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FMRP plays a major role in the regulation of translation at
the synapses. Several works have tried to scan for possible
targets of FMRP thatmay explain the broad neurocognitive
phenotype of FXS. Although many key neuronal proteins
were found to be regulated by FMRP, there are still much
data missing to explain the molecular pathology. In this
work, we have chosen a different approach; rather than
searching for FMRP targets, we have analyzed the global
transcriptomic changes that occur in the absence of
FMRP and linked these changes to the molecular pheno-
type of the disease. The strength of our model system
enabled us to look at these changes at different develop-
mental stages. FMRP may be expressed in human ESCs
that carry a full mutation (Colak et al., 2014; Eiges et al.,42 Stem Cell Reports j Vol. 4 j 37–46 j January 13, 2015 j ª2015 The Author2007). In this sense, the FXS-derived iPSCs are different,
as the FMRP locus was found by us and others to be epige-
netically resistant to the process of reprogramming (Alisch
et al., 2013; Urbach et al., 2010). With this in mind, we
have set to analyze the differences between FXS-derived
and control iPSCs. We demonstrated that FXS and control
derived iPSCs are highly similar, at the undifferentiated
state (Figures 1A, 1B, and S1A). As FXS patients suffer
from a neural pathology, we speculated that neurons
derived from FXS-iPSCs would exhibit significant differ-
ences when compared with neurons derived from control
iPSCs. We indeed found a large number of genes to be
differentially expressed between the two groups (Figures
1C and S1A). The downregulated genes in FXS are mostly
those related to neuron differentiation, axonogenesis,
and the axon guidance pathway (Figures 1C and 1D).s
FMRP REST
Axon 
Guidance 
Genes
WT
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Neural
miR-382
RESTNeuralmiR-382
Axon 
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Figure 5. Schematic Representation of the Molecular Pathway
Aberrant in FXS
In control (WT) neurons, FMRP is important for the regulation of
the level of the mature hsa-mir-382. hsa-mir-382 in turn affects the
regulation of REST during the maturation of the neurons, thus al-
lowing the expression of the axon guidance genes. In FXS-derived
neurons, FMRP is not produced; hsa-mir-382 levels are very low and
insufficient for the downregulation of REST. REST levels do not
decrease, resulting in the suppression of the axon guidance genes.
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errations in neural development, abnormalities of den-
dritic spine morphologies, and deformities of growth
cone development affecting axon guidance in the forma-
tion of FXS neurons (Antar et al., 2006; Bassell andWarren,
2008; Callan et al., 2010; Castre´n et al., 2005; Comery et al.,
1997; Egger et al., 2008; Irwin et al., 2001; Li et al., 2009;
Luo et al., 2010; Tessier and Broadie, 2008).
Many of the genes that take part in these cellular andmo-
lecular processes were found to be regulated by REST. In
fact, different studies aimed to identify REST target genes
indicated that REST is involved in processes such as ner-
vous system development, neuron projection, and axonal
guidance signaling. Some of these studies have also sug-
gested REST to play a part in glutamate receptor signaling
(Bruce et al., 2004; Johnson et al., 2007; Satoh et al.,
2013). This findingmay in fact connect aberrant regulation
of REST to the abnormal activity of the glutamate receptor
signaling seen in FXS neurons (Do¨len et al., 2007) or may
cause an additive effect. It is becoming clear from recent
studies that REST is a key regulator of proper neural differ-
entiation and development, and any perturbation in the
regulation of REST will eventually lead to abnormalities
in creating the neural network (Ballas et al., 2005; Covey
et al., 2012; Paquette et al., 2000). Constitutive expression
of REST in differentiating neurons was found to disrupt
neural gene expression and caused significantly higher fre-
quencies of axon guidance errors but did not prevent neu-
rogenesis (Paquette et al., 2000). As we could not detect
differences in REST levels in NPCs, we believe that the
abnormal regulation seen in FXS occurs at the stage of
mature neuronal development and network formation
(Figures S2A and S2B). In this sense, the molecular pheno-
types seen in FXS-derived neurons mimic the molecular
phenotypes seen in neurons expressing higher levels ofStemREST and reinforce our finding of aberrant REST regulation
in FXS cells.
As FMRP is involved in themiRNAmachinery, we sought
to explore the possibility that the regulation of REST by
FMRP is mediated by miRNA levels in our iPSCs derived
neurons. Global analysis of miRNAs expression in FXS cells
and control cells revealed that at 4-fold cutoff we identify
only miRNAs that are downregulated (and not upregu-
lated) in FXS-derived neurons (Figure 3B). This finding
may point to an important role for FMRP in the regulation
of specific neural miRNAs. Of the candidate miRNAs iden-
tified, hsa-mir-382 was found to be enriched in the brain
(Mor et al., 2013) and harbors two binding sites on the
REST transcript (Figure 3C). Indeed, genetic manipulation
of hsa-mir-382 affected REST expression in both iPSCs
and FXS-derived neurons (Figures 3D and 4A–4C). Most
importantly, overexpression of hsa-mir-382 was able to
significantly upregulate the levels of the REST target axon
guidance genes in FXS-derived neurons (Figure 4D). The
specific role of FMRP in the maturation and function of
neural miRNAs should be further studied in the future, as
miRNAs are major posttranscriptional regulators affecting
the levels of proteins, which are critical for proper neural
differentiation and synaptic function.
In this work, we have shown the dramatic effect of the
loss of FMRP on the gene expression profile of neurons.
In the absence of FMRP, the neural hsa-mir-382 levels
are decreased, preventing the differentiation-dependent
downregulation of REST. The resulting higher levels of
REST in FXS-derived neurons cause the suppression of
neural genes important for proper axon development (Fig-
ure 5).We strengthen the importance of FMRP in thematu-
ration and formation of the neural network through its
interaction with the miRNA pathway and regulation of
REST. Our work lays a foundation for identifying a
biomarker for early detection of the syndrome in affected
embryos and suggests several candidates for targeted ther-
apy. Recent studies suggest that REST plays a key role in
the pathological process of different human neurodegener-
ative diseases (Gonza´lez-Castan˜eda et al., 2013; Marullo
et al., 2010; Zuccato et al., 2003). The role of REST in FXS
should be furthered explored as well as the part that
miRNAs play in the development of this pathology.EXPERIMENTAL PROCEDURES
Cell Culture
Cell culture and neuronal differentiation were previously
described (Bar-Nur et al., 2012). We have differentiated iPSCs to
NPCs according to a protocol published by Kim et al. (2010) with
two inhibitors (Dorsomorphin and SB431542). At the end of the
differentiation process, we stained the cells for NCAM1 and sorted
only for positive cells using fluorescence-activated cell sorting. InCell Reports j Vol. 4 j 37–46 j January 13, 2015 j ª2015 The Authors 43
Table 1. Primers List
Gene Name Forward Primer Reverse Primer
REST ATTGGAATGGCCCTGCCTAA CCAGTTAAGGCCACATTTGCC
ROBO3 CGAGAGGAACCAAGATGACCCT GCCAATTGAAATCGTGGAAACC
DCC GGCAGACTTCCAGTTGCACTCT CCCATGCCCCTGTGTTTATTAA
SLIT1 GGAATCTGCCGCAAAAAGTCA CACACTGAATCTCCTGGCCAA
GAPDH AGCCACATCGCTCAGACACC GTACTCAGCGGCCAGCATCG
NESTIN ATCTGCAAACCCATCGGACTC TGAGGCACCTTTTCTTCCTGG
TUBB3 CCTCTTCTCACAAGTACGTGCC AGGCCTGAAGAGATGTCCAAA
HOMER3 AGATGCTGTTCAGAGGCAAAG AGGCCATCATCAACAGCACTG
Table 2. miRIDIAN miRNA Mimic List
mimic-mir-382 GAAGUUGUUCGUGGUGGAUUCG
mimic-mir-370 GCCUGCUGGGGUGGAACCUGGU
mimic-mir-409 AGGUUACCCGAGCAACUUUGCAU
mimic-negative-control UCACAACCUCCUAGAAAGAGUAGA
Stem Cell Reports
Molecular Defects of FXS-iPSCs-Derived Neuronsthis study, we have used two control cell lines, BJ-iPSCs 28 and BJ-
iPSCs 94, and five different FXS-derived iPSC clones from three
different patients: patient A with clones 47, 52, and 55; patient B
with clone 40; and patient C with clone 2 (Bar-Nur et al., 2012;
Urbach et al., 2010).
RNA Isolation and Reverse Transcription
RNA was isolated using PerfectPure RNA Cultured Cell Kit-50
(5 PRIME). One microgram of total RNA was used for reverse
transcription reaction using ImProm-II reverse transcriptase
(Promega). For sequencing and quantitative experiments, PCRs
were performed with ReadyMix (Sigma); for overexpression exper-
iments, PCR reactions used Herculase II Fusion DNA polymerase
(Agilent Technologies). Quantitative real-time PCR was performed
with 1 mg of RNA reverse transcribed to cDNA and TaqManUniver-
salMasterMix or SYBRGreen qPCR Supermix (see the primer list in
Table 1; Applied Biosystems) and analyzed with the 7300 real-time
PCR system (Applied Biosystems).
DNA Microarray Analysis
Total RNA was extracted according to manufacturer’s protocol
(Affymetrix). RNAwas subjected toHumanGene 1.0 STmicroarray
platform (Affymetrix) analysis; washing and scanning were per-
formed according to manufacturer’s protocol. Arrays were
analyzed using Robust Multichip Analysis in the Affymetrix
Expression Console.
miRNA Expression Analysis
Total RNA was extracted using MirVana miRNA isolation kit (Am-
bion) according to themanufacturer’s protocol. RNAwas subjected
to Human GeneChip miRNA array platform analysis (Affymetrix);
washing and scanning were performed according to the manufac-
turer’s protocol. Arrays were analyzed using miRNA QC Tool.
Overexpression of miRNA
miRIDIAN miRNA Mimics by Thermo Scientific were transfected
into control iPSCs or FXS-derived neurons using Lipofectamine
2000 by Invitrogen according to manufacturer protocol. At 30 or
45 hr after transfection, cells were harvested for RNA or lysed for
protein (see the mimics sequences in Table 2).44 Stem Cell Reports j Vol. 4 j 37–46 j January 13, 2015 j ª2015 The AuthorWestern Blot Analysis
Ten percent polyacrylamide gel was used for protein separa-
tion. The gel was transferred to a nitrocellulose membrane,
and antibody hybridization and chemiluminescence were per-
formed according to the standard procedures. The primary
antibodies used in this analysis were mouse anti-NRSF sc-
374611 (SANTA CRUZ) and mouse antitubulin (Sigma). HRP-
conjugated antirabbit and antimouse secondary antibodies were
obtained from Jackson ImmunoResearch Laboratories. Western
blot quantification was performed using the FUJIFILM Image
Gauge software.Functional Annotations and Motif Search
Functional annotations were achieved by subjecting differentially
expressed genes to the DAVID functional annotation clustering
tool (http://david.abcc.ncifcrf.gov/). Motifs were searched the
same way by using both the DAVID functional annotation clus-
tering tool (http://david.abcc.ncifcrf.gov/), the Amadeus BPM
v.1.0 software (http://acgt.cs.tau.ac.il/allegro/), and PRIMA anal-
ysis (http://acgt.cs.tau.ac.il/prima/). Pathways search was per-
formed using the KEGG (http://www.genome.jp/kegg/).ACCESSION NUMBERS
The Gene Expression Omnibus (GEO) accession number for the
data reported in this paper is GSE62721.SUPPLEMENTAL INFORMATION
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